"There is a strong emphasis on advancing responsible and trusted AI governance, combining policy clarity with industry-led ...
Discover why Microsoft (MSFT) offers 22% upside by 2026 despite market concerns. Learn about key growth drivers and why the ...
HONG KONG, Dec. 30, 2025 /PRNewswire/ — Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed ...